AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
Go back to AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026| Amgen Inc (NASDAQ: AMGN) | Delayed: 355.20 +1.14 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $354.06 | 52 Week High | $176.85 | |||
| Open | $357.39 | 52 Week Low | $133.64 | |||
| Day High | $358.17 | P/E | 53.49 | |||
| Day Low | $351.96 | EPS | $6.64 | |||
| Volume | 2,730,230 | |||||

